← Back
Research Paper Volume 13, Issue 6 pp 8975—8988

PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival

class="figure-viewer-img"

Figure 1. Flow diagram for selection of studies.